Atlas Trials

Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung Cancer

Clinical trial NCT00856037 · COMPLETED

Trial details

NCT number
NCT00856037
Sponsor
University of Nebraska
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Small Cell Lung Carcinoma
Start date
2009-02-02
Primary completion
2018-02-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.